Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2023
Affiliations
Immutep (Germany)(Current)
M.-R. Rafiyan is an author at Immutep (Germany).
Publications per year
2023–2023
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology
S-E. Al-Batran, Daniel Mueller, M.-R. Rafiyan et al. · ESMO Open · 2023 · 10 citations · Full text
1–1 of 1